# Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

> **NCT01422759** · NA · UNKNOWN · sponsor: **University of Virginia** · enrollment: 20 (estimated)

## Conditions studied

- Obesity
- Hyperandrogenemia
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT01422759
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12-09
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422759, "Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01422759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*